• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可生物降解的氧氟沙星的核壳型微球的设计:配方参数对体外特性的影响。

The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.

机构信息

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Haydarpasa, Istanbul, Turkey.

出版信息

Pharm Dev Technol. 2012 Jan-Feb;17(1):118-24. doi: 10.3109/10837450.2010.529145. Epub 2010 Oct 26.

DOI:10.3109/10837450.2010.529145
PMID:20977313
Abstract

Ofloxacin (OFL), second-generation fluoroquinolone, is a broad-spectrum antibiotic which is active against both Gram-positive and Gram-negative bacteria. However, OFL has a short biological half life (8-9 h) and poor stability in serum and needs frequently repeated doses during the treatment. The objective of this study was to fabricate the fucospheres and chitosan microspheres containing a poorly soluble drug, OFL, and to compare the formulation parameters influencing the in vitro properties of microparticles such as size, zeta potential, encapsulation efficiency and drug release characteristics. Particle size of fucospheres and chitosan microspheres has been found to be 0.61-1.48 µm and 1.05-2.08 µm, respectively. The zeta potentials have changed between 5.6 mV and 28.0 mV for fucospheres; 22.3 mV and 42.4 mV for chitosan microspheres. The fucospheres have had higher drug encapsulation efficiency than those of chitosan microspheres. The particle size, surface charge, encapsulation efficiency and in vitro drug release from both fucospheres and chitosan microspheres have been affected by type and concentration of the polymers used. The release mechanism from most of the microsphere formulations has been fitted to Higuchi kinetic model. It can be concluded that OFL-encapsulated fucospheres can be a potential delivery system for antibiotics.

摘要

氧氟沙星(OFL)是第二代氟喹诺酮类药物,属于广谱抗生素,对革兰氏阳性菌和革兰氏阴性菌均有活性。然而,OFL 的生物半衰期(8-9 小时)较短,在血清中的稳定性差,在治疗过程中需要频繁重复给药。本研究的目的是制备载有疏水性药物氧氟沙星的藻酸盐微囊和壳聚糖微球,并比较影响微球体外性质的制剂参数,如粒径、Zeta 电位、包封率和药物释放特性。藻酸盐微囊和壳聚糖微球的粒径分别为 0.61-1.48μm 和 1.05-2.08μm。藻酸盐微囊的 Zeta 电位在 5.6mV 到 28.0mV 之间变化;壳聚糖微球的 Zeta 电位在 22.3mV 到 42.4mV 之间变化。藻酸盐微囊的载药包封率高于壳聚糖微球。藻酸盐微囊和壳聚糖微球的粒径、表面电荷、载药包封率和体外药物释放均受到所用聚合物的类型和浓度的影响。大多数微球制剂的释放机制均符合 Higuchi 动力学模型。可以得出结论,氧氟沙星包封的藻酸盐微囊可以作为抗生素的潜在给药系统。

相似文献

1
The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.基于可生物降解的氧氟沙星的核壳型微球的设计:配方参数对体外特性的影响。
Pharm Dev Technol. 2012 Jan-Feb;17(1):118-24. doi: 10.3109/10837450.2010.529145. Epub 2010 Oct 26.
2
Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.用于左氧氟沙星递送的喷雾干燥壳聚糖微球的制备及其体外释放
J Control Release. 2011 Nov 30;152 Suppl 1:e70-1. doi: 10.1016/j.jconrel.2011.08.129.
3
A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.基于壳聚糖和蒙脱石的 pH 敏感纳米复合微球具有体外降低突释效应。
Drug Dev Ind Pharm. 2010 Sep;36(9):1106-14. doi: 10.3109/03639041003677798.
4
Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.载有醋氯芬酸的壳聚糖微球的配方与评估用于结肠靶向药物传递。
Biopharm Drug Dispos. 2010 Oct;31(7):407-27. doi: 10.1002/bdd.722.
5
Facile preparation of magnetic 2-hydroxypropyltrimethyl ammonium chloride chitosan/Fe3O4/halloysite nanotubes microspheres for the controlled release of ofloxacin.磁性 2-羟丙基三甲基氯化铵壳聚糖/Fe3O4/埃洛石纳米管微球的简便制备及其用于氧氟沙星的控制释放。
Carbohydr Polym. 2014 Feb 15;102:877-83. doi: 10.1016/j.carbpol.2013.10.071. Epub 2013 Nov 7.
6
Formulation and in vitro characterization of spray dried microspheres of amoxicillin.阿莫西林喷雾干燥微球的制备及体外特性研究。
Acta Pharm. 2010 Dec;60(4):455-65. doi: 10.2478/v10007-010-0034-7.
7
Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.用于酮咯酸鼻腔给药的黏膜黏附微球的研制与表征
Pharmazie. 2011 Apr;66(4):249-57.
8
The use of fucosphere in the treatment of dermal burns in rabbits.富球在兔皮肤烧伤治疗中的应用。
Eur J Pharm Biopharm. 2008 May;69(1):189-98. doi: 10.1016/j.ejpb.2007.09.004. Epub 2007 Sep 20.
9
beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.β-雌二醇可生物降解微球:制剂参数对包封率和体外释放的影响
Pharmazie. 2006 Sep;61(9):775-9.
10
Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics.藻酸盐微球和壳聚糖微球包封质粒 DNA(pGM-CSF)的体外特性比较: 制剂设计和释放特性。
AAPS PharmSciTech. 2009;10(4):1193-9. doi: 10.1208/s12249-009-9324-0. Epub 2009 Oct 27.

引用本文的文献

1
Contemporary Aspects of Designing Marine Polysaccharide Microparticles as Drug Carriers for Biomedical Application.设计海洋多糖微粒作为生物医学应用药物载体的当代研究进展
Pharmaceutics. 2023 Aug 11;15(8):2126. doi: 10.3390/pharmaceutics15082126.
2
Novel Fucoidan Pharmaceutical Formulations and Their Potential Application in Oncology-A Review.新型岩藻依聚糖药物制剂及其在肿瘤学中的潜在应用——综述
Polymers (Basel). 2023 Jul 29;15(15):3242. doi: 10.3390/polym15153242.
3
Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems.
药用级褐藻糖胶:智能药物输送系统的综合评价。
Mar Drugs. 2023 Feb 4;21(2):112. doi: 10.3390/md21020112.
4
Seaweed Phenolics as Natural Antioxidants, Aquafeed Additives, Veterinary Treatments and Cross-Linkers for Microencapsulation.海藻酚类作为天然抗氧化剂、水产饲料添加剂、兽医治疗药物和微胶囊交联剂。
Mar Drugs. 2022 Jul 7;20(7):445. doi: 10.3390/md20070445.
5
Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms.褐藻糖胶在药物剂型开发中的应用可能性。
Mar Drugs. 2019 Aug 5;17(8):458. doi: 10.3390/md17080458.
6
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.硫酸化海藻多糖作为药物递送应用中的多功能材料
Mar Drugs. 2016 Feb 25;14(3):42. doi: 10.3390/md14030042.